| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA697864 | F | Inhibition of growth of tumor cells, manca human lymphoma cells | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 2. | ALA707652 | F | Antiproliferative effect against human lymphoma cells was determined; (0.012 to 0.12 nM) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA707653 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 2 ug/mL | Mus musculus | 15 | cell-based format | Scientific Literature | ||
| 4. | ALA707654 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 20 ug/mL | Mus musculus | 13 | cell-based format | Scientific Literature | ||
| 5. | ALA707655 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 4 ug/mL | Mus musculus | 2 | cell-based format | Scientific Literature | ||
| 6. | ALA707656 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 5 ug/mL | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA880751 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
| 8. | ALA707657 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 20 ug/mL. | Mus musculus | 13 | cell-based format | Scientific Literature | ||
| 9. | ALA707658 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
| 10. | ALA707659 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 5 ug/mL. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA707660 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
| 12. | ALA707661 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 5 ug/mL. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA707662 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 20 ug/mL. | Mus musculus | 13 | cell-based format | Scientific Literature | ||
| 14. | ALA712665 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
| 15. | ALA712666 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
| 16. | ALA712667 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 20 ug/mL. | Mus musculus | 13 | cell-based format | Scientific Literature | ||
| 17. | ALA712668 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA712669 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 5 ug/mL. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA821478 | F | Percent decrease of Lymphoma mass of animals treated with the compound | 2 | cell-based format | Scientific Literature | |||
| 20. | ALA4369877 | T | Clastogenicity in mouse Lymphoma cells at 5 ug/ml | Mus musculus | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!